Cargando…
Early Predictor Tool of Disease Using Label-Free Liquid Biopsy-Based Platforms for Patient-Centric Healthcare
SIMPLE SUMMARY: We proposed a comprehensive early prediction tool based on liquid biopsy for the label-free phenotypic analysis of cell clusters from clinical samples (n = 31). Our custom algorithm analysis, combined with a microfluidic-based tumor model, was designed to assess and stratify cancer p...
Autores principales: | Li, Wei, Zhou, Yunlan, Deng, Yanlin, Khoo, Bee Luan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834418/ https://www.ncbi.nlm.nih.gov/pubmed/35159085 http://dx.doi.org/10.3390/cancers14030818 |
Ejemplares similares
-
Label-free enrichment of human blast cells from whole blood for leukemia monitoring
por: Fu, Yatian, et al.
Publicado: (2022) -
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
por: Khoo, Bee Luan, et al.
Publicado: (2019) -
Fasting to enhance Cancer treatment in models: the next steps
por: Zhang, Jing, et al.
Publicado: (2020) -
VTX‐1 Liquid Biopsy System for Fully‐Automated and Label‐Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform
por: Sollier‐Christen, Elodie, et al.
Publicado: (2018) -
Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
por: Khoo, Bee Luan, et al.
Publicado: (2016)